Glycolipids, the predominant class of lipids in the membranes of Acholeplasma laidlawii, are the haptenic determinants that react with anti-A. laidlawii serum to fix complement. The predominant complement-fixing activity of the membrane glycolipids was associated with the monoglucosyl diglyceride, diglucosyl diglyceride, glycerylphosphoryl diglucosyl diglyceride (GPDD), and an unknown lipid B, which did not react with ninhydrin but released glucose and glycerol and traces of phosphorus upon hydrolysis. The glycolipids monoglucosyl diglyceride and diglucosyl diglyceride or GPDD and unknown lipid B were paired as a result of their cross-reactions with selective antisera prepared with the aid of reconstituted membrane complexes containing membrane lipids. Reconstituted membrane complexes assembled from ['4C]monoglucosyl diglyceride and delipidated membrane proteins gave optimal complement fixation titers before saturation of the complexes with the [14C]monoglucosyl diglyceride. The phosphoglycolipid of the membrane, GPDD, was anticomplementary as a pure lipid, a cholesterol liposome, and a reconstituted membrane complex. This anticomplementary activity, which was caused by 3 ,ug of pure GPDD, affected both human and guinea pig complement. Although human Cl, C4, C3, and C5 were not inhibited by GPDD, C2 was inhibited 10-fold by reconstituted membrane complexes containing 150 ,ug of GPDD. A role for this phosphoglycolipid is discussed in the hypothetical mechanism of inhibition of C2 attachment to SAC1, 4 sites.
The glycolipids of mycoplasmal membranes, the haptenic determinants that react with specific antibody to fix complement (21) , are intimately involved in the mechanism of immune lysis (4) and are easily complexed with heterologous or homologous delipidated membrane proteins for immunogenic purposes (29) . The immunological properties of the membrane glycolipids from Acholeplasma laidlawii (21, 38 (34, 35) and because of the recent advances in understanding the ultrastructure of the membrane of A. laidlawii (40) . Studies of the antigenic properties of glycolipids from A. laidlawii have been complicated by the anticomplementary (AC) activity of both cells (5) and extracted lipids (3) . The anticomplementarity of individual immunologically active lipids (26) , particularly the phosphatidyl glycerol from Mycoplasma pneumoniae, suggested the association of the AC activity of A. laidlawii with a lipid, perhaps a glycolipid, of the membrane. Although some
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immunochemically active lipids reportedly interfere with complement in a nonspecific manner (26) , studies using purified complement components and lipid-sensitized liposomes (12) suggested a more specific role for these lipids in complement inactivation. The object of this study was to determine the complement-fixing haptenicity and the AC activity of specific glycolipids from the membrane of A. laidlawii.
MATERIALS AND METHODS Preparation of membrane suspensions. Cells of
A. laidlawii (ATCC 14192) were harvested after growth on tryptose media, pH 7.5, for 16 h at 37 C (23). Membranes were isolated from sonicated cell suspensions (27) by centrifugation at 100,000 x'g for 1 h in a model L2-65B Beckman ultracentrifuge. Membranes were either resuspended in a 1:20 dilution of 0.5 M tris(hydroxymethyl)aminomethane buffer containing 0.01 M MgCl2 and 0.01 M ,jmercaptoethanol (1/20 /S buffer) (27) or lyophilized and stored at 4 C.
Isolation of membrane glycolipids. Lipids were extracted from lyophilized membranes with chloroform-methanol (2:1) at room temperature. The extracted membranes were removed from the supernatant by centrifugation after each of three extrac-tions. Although chloroform-methanol (2:1) was most effective as a solvent, releasing 32.5% of the membrane dry weight as lipid, membrane suspensions were also extracted with 90% cold acetone, 1/20 /8 buffer, or 0.01% saponin in 1/20 ,3 buffer. The relative amount of each lipid extracted varied with the extraction procedure. Dry weight was determined by deposition of the lipid on constant-weight planchets and drying under vacuum over silica gel until a constant weight was obtained. The sugar content of lipids was estimated by the phenol-sulfuric acid assay (9) , and the total carbon content was determined by the dichromate-sulfuric acid test (2) (36) , and staining chromatoplates with periodate-Schiff reagents (32) . Other polar lipids were identified by co-chromatography with known compounds. Lipids separated on chromatoplates were extracted from the dislodged gel with chloroform-methanol (2:1) at least three times. Lipids extracted from the sedimented gel were estimated by the dichromate-sulfuric acid and/or the phenol-sulfuric acid assays. Lipids were isolated in larger amounts for use in immunological tests by extraction of lyophilized membrane preparations with chloroform-methanol (2:1) and column chromatography on silicic acid (34) and by concomitant thin-layer chromatography (TLC) on silica gel H. Extensively rechromatographed lipid antigens were prepared by silicic acid chromatography, TLC with chloroform-methanol-water at least twice, and finally two-dimensional TLC at least twice with chloroform-methanol-water and propanol-ammonium hydroxide-water. [14C]monoglucosyl diglyceride, used to determine optimum protein/lipid ratios for complement fixation, was biosynthesized by incubation of a 1.0-ml membrane suspension (2.0 mg of protein/ml) with 0.025 ml of [U-14C]uridine diphosphate glucose (New England Nuclear Corp.) at 37 C for 1 h. It was isolated after extraction of the incubation mixture with chloroform-methanol (2:1) Preparation of cholesterol-lecithin liposomes. Cholesterol-lecithin liposomes were prepared by evaporating chloroform-methanol (2: 1)-solubilized membrane lipids to dryness followed by resolubilization in a chloroform-methanol (2:1) solution of lecithin (1.0 mg/ml). I'he lipid-lecithin complex was evaporated to dryness and resuspended in a cholesterol suspension in 10% ethanol in distilled water (20 mg/ml) to a final molar ratio of 10:1 cholesterol to lecithin in the final liposome (21) .
Antisera. Anti-A. laidlawii serum was prepared in rabbits by subcutaneous injection of 1.0 ml (15-20 mg of cellular protein) of A. laidlawii (grown in tryptose media [23] supplemented with 1% rabbit sera) with complete Freund adjuvant (1:1) three to six times at 10-to 14-day intervals. Selective antisera were prepared by absorbing anti-A. laidlawii serum with reconstituted membrane complexes containing membrane protein and all glycolipids except one for 30 min at 37 C and sedimenting at 100,000 x g for 1 h at 4 C to remove antigen-antibody complexes. The supernatant from the third antigenantibody absorption was considered selective antiserum.
Complement. Guinea pig complement was used throughout, except in studies on complement components in which human complement components and stable cellular intermediates (Cordis Laboratories, Miami, Fla.) were substituted. Human complement components were used in hemolytic assays (20) to determine inhibition of specific complement components.
Complement fixation tests. Membrane or lipid antigens that had been grown in tryptose media (23) supplemented with porcine sera were assayed using standard complement fixation procedures (15, 25) by reaction with anti-A. laidlawii serum. After elution from chromatoplates, the lipid antigens were stabilized and enhanced by sensitizing cholesterol-lecithin liposomes (21) with the lipids. Veronal buffer (0.147 M) (VB2"), pH 7.2, containing 0.0003 M Mg2" and 0.00015 M Ca2l was used throughout. Complement fixation microtiter tests were conducted by using 0.05 ml of VB2+, 0.025 ml of lipid antigen, 0.025 ml of inactivated antiserum, and 0.025 ml (2 U) of complement added to wells of V microtiter plates. After incubation at 37 C for 1 h, 0.025 ml of a standardized 2.0% suspension of sensitized sheep erythrocytes was added, and samples were reincubated at 37 C for 1 h and allowed to settle for 1 to 2 h. The complement fixation titer was the reciprocal of the highest dilution of antiserum that resulted in 50% hemolysis as visually approximated. Isofixation curves (25) were determined by complement fixation tube tests using 0.9 ml of G1-GVB2+, which consists of equal volumes of VB2+, 5% glucose in distilled water, and this mixture made up to 0.1% gelatin with a distilled water solution of 1.0% gelatin, 0.2 ml of lipid antigen, 0.2 ml of rabbit anti-A. laidlawii serum, and 0.2 ml (2 to 6 U) of complement. After incubating for 1 h in a 37 C shaking water bath, 0.2 ml of a standardized indicator system was added. Reincubation in a 37 C shaking water bath for 1 h was followed by a 5-min incubation at 4 C and a 5-min centrifugation at 1,500 x g. An end point of 50% hemolysis was determined by reading optical density of the reaction supernatant at 545 nm in a Zeiss 
RESULTS
Complement fixation by the polar lipids extracted from membranes of A. laidlawii. Membranes (antigen 1) of A. laidlawii extracted with 90% cold acetone yielded lipid extracts (antigen 2) that consistently gave higher titers than native membranes (Table 1) . Delipidated membrane protein ( Table 1 , antigen 3) possessed no complement-fixing activity, and when reconstituted with membrane-lipid mixture (Table 1 , antigen 4), it gave higher titers than when reconstituted with isolated glycolipids (Table 1 , antigens 5 and 6). Minimally delipidated membrane proteins or slightly altered membrane vesicles extracted with 0.01% saponin (Table 1 , antigens 7 and 8) also consistently reacted differently than native membrane vesicles.
Lipid extracts were separated into seven easily recognizable and rather homogeneous (28) lipids on silica gel H chromatoplates. The lipids were tested serologically after binding to cholesterol-lecithin liposomes, which gave much better experimental reproducibility than individual lipids (22) . Monoglucosyl diglyceride, diglucosyl diglyceride, GPDD, unknown lipid B, and phosphatidyl glycerol, whose immunological properties have been debated in the literature (7, 28) and which may be contaminated with trace amounts of GPDD, all reacted with anti-A. laidlawii serum ( Table 2 , column C). The complement-fixing reactivity of the lipid aliquots was not directly related to lipid content of the membrane (percent dry weight), but the lipids that contained glucose (['Clglucose incorporation) were the predominant complementfixing determinants of the membrane. This became increasingly evident when the glucose content of unknown B was determined upon hydrolysis and when the AC activity of GPPD was diluted out or was not effective, as against antiserum absorbed with acetone-extracted membranes ( Table 2 , column E). Membrane suspensions from A. laidlawii that contained all of the membrane lipids absorbed nearly all, whereas acetone-extracted membrane suspensions that contained only trace amounts ofmembrane lipids absorbed only trace amounts, of the antibody-to-membrane lipids in anti-A. laidlawii serum (Table 2 , columns D and E).
Membrane lipids were tested for antigenicity by combination with delipidated membrane proteins after 90% cold-acetone extraction of membrane (Table 2 , column F). These reconstituted membrane complexes containing individual lipids were immunologically specific for the reconstituted lipid (Table 2 , column G). The highest complement-fixing titers without AC activity were observed in preparations E, H, and I (Table 3). Because preparation E contained five times more antigen and preparation H took so long to reconstitute, the reconstituted membrane complexes of preparation I ( Table 3) that were formed by melting together SDS solutions of delipidated membrane proteins and extracted membrane lipids after dilution with 100 mM Mg2+ were used throughout the study. The relationship between the complement-fixing titers, the amount of lipid, and the amount of protein in these complexes (Fig. 1A) (Fig. 1B) .
The complement-fixing titers against the reconstituted membrane complexes containing Table 2 ). The complement-fixing antibodies of the absorbed anti-A. laidlawii serum selective for individual lipids could be completely absorbed with membrane vesicles or reaggregated membrane complexes containing a mixture of membrane lipids, but could not be absorbed with acetoneextracted membranes. Furthermore, when a reconstituted membrane complex containing all the lipids except diglucosyl diglyceride was used to absorb the anti-A. laidkawii serum, the activity against diglucosyl diglyceride was the only remaining complement-fixing activity of the antiserum ( Table 2) .
Selectivity of the anti-A. laidlawii serum after absorption with reconstituted membrane complexes. Extensively rechromatographed monoglucosyl diglyceride, diglucosyl diglyceride, GPDD, and unknown lipid B (see Materials and Methods) were differentiated and identified by using selective antisera (Table 4). Except in the reactions that were complicated by the AC activity of GPDD, the observed complement fixation titers using sensitized cholesterol-lecithin liposomes were at least four times the titer found for nonreacting purified lipids ( Table 4 ). The lowered concentration of monoglucosyl diglyceride and diglucosyl diglyceride in the chloroform-methanol column effluent (Table 4 Table 2 , column D) and the isofixation curve of the protein-GPDD complex (Fig. 2) . The AC activity of GPDD was evident with 3 ,ug of the pure lipid (Fig. 3A) . In contrast, the GPDDreconstituted membrane complex required 60 pg to reach optimal anticomplementarity (Fig.  3B ), but the level of anticomplementarity was greater. The AC action of GPDD was effective against both human and guinea pig complement. Ten micrograms of GPDD inhibited 13 50% hemolytic complement (CHO) units of guinea pig complement (Fig. 3B) (4, 18) . Liposomes sensitized with lipid haptens also undergo immune lysis, and studies on sensitized liposomes have revealed that the enzymatic degradation of lipids is not involved in immune lysis (12, 13, 17) . The C2 and C8 components of complement are essential for complement action in immune lysis of liposomes, although the efficiency of the reaction is increased when all the components are present (11) . As in immune lysis, which requires surface availability of glycolipids to spe- (B) Anticomplementarity of a reconstituted membrane complex containing GPDD. The 50% end point was approximated visually from the anticomplementarity microtiter test and determined spectrophotometrically using the anticomplementarity tube test with 2 U of guinea pig complement. A CH50 unit of complement is that amount of complement necessary to achieve 50% hemolysis of the indicator system. 1CH50 units represent a loss of hemolytic activity of guinea pig complement after incubation with GPDDcomplex. cific antibodies and subsequent binding of complement, the AC action of GPDD also requires surface localization for its interaction with complement components or complexes that are impermeable to the membrane of A. laidlawii. GPDD probably inhibits C2, one of the complement components essential for hemolysis (19, 24) . Although Cl, C4, C3, and C5 are not inhibited by GPDD, our data do not exclude additional inhibition of C6 through C9. The mechanism of C2 inhibition relies upon the decreased generation of SAC4, 2 sites (19) . The generation of fewer numbers of C4, 2 sites could be caused by (i) repression of the cleavage of C2 by Cl serine esterase of the SAC1, 4 complex (18), thus limiting the availability of C2a, the cleaved fragment, for completion of the SAC1, 4, 2a complex; (ii) blockage of the attachment of C2a to the membrane-bound SAC1, 4; or (iii) binding and/or inactivation of C2a by GPDD instead of SAC1, 4. Our results do not favor any of these mechanisms at this time.
Other phosphoglycolipids with structures similar to GPDD (33) , recently isolated and characterized, differ from the phosphoglycolipid from A. laidlawii, which is unique in having the glycerophosphate residue on the terminal glucose. The occurrence ofthese phosphoglycolipids in streptococcal cells (8, 10, 14) suggests a general role for them in AC action, in addition to their role as intermediates in the biosynthesis of teichoic acids (1, 39, 41) .
